Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome

Retina

Volumn 23, Issue 3, 2003, Pages 299-306

  Busquets, M A ^a,b,e   Shah, Gaurav K ^a,b   Wickens, J ^b   Callanan, D ^c   Blinder, K J ^a,b   Burgess, D ^a,b   Grand, M G ^a,b   Holekamp, N M ^a,b   Boniuk, I ^a,b   Joseph, D P ^a,b   Thomas, M A ^a,b   Fish, E ^c   Bakal, J ^d   Hollands, H ^d   Sharma, S ^d  

^a BARNES RETINA INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Retina Institute of Texas   (United States)

^d QUEEN S UNIVERSITY   (Canada)

^e Associates in Ophthalmology   (United States)

Author keywords

Choroidal neovascularization (CNV); Ocular histoplasmosis syndrome (OHS); Ocular photodynamic therapy (OPT); Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DATA ANALYSIS; DEMOGRAPHY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MALE; OCULAR HISTOPLASMOSIS; PHOTODYNAMIC THERAPY; STATISTICAL ANALYSIS; SUBRETINAL NEOVASCULARIZATION; SURGICAL STRESS; VISUAL ACUITY;

EID: 0037742639     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200306000-00003     Document Type: Article

References (21)

1. Kleiner RC, Ratner CM, Enger C, Fine SL. Subfoveal neovascularization in the ocular histoplasmosis syndrome: a natural history study. Retina 1988;8:225.
2. Olk RJ, Burgess DB, McCormick PA. Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Ophthalmology 1984;91:1592.
3. Macular Photocoagulation Study Group. Argon laser photocoagulation for ocular histoplasmosis. Results of a randomized clinical trial. Arch Ophthalmol 1983;101:1347-1357.
4. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Arch Ophthalmol 1987;105:1499-1507.
5. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Arch Ophthalmol 1991;109:1109-1114.
6. Cummings HL, Rehmar AJ, Wood WJ, Isernhagen RD. Long-term results of laser treatment in the ocular histoplasmosis syndrome. Arch Ophthalmol 1995;113:465-468.
7. Fine SL, Wood WJ, Isernhagen RD, et al. Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome: results of a pilot randomized clinical trial. Arch Ophthalmol 1993;111:19-20.
8. Thomas MA, Grand MG, Williams DF, et al. Surgical management of subfoveal choroidal neovascularization. Ophthalmology 1992;99:952-968.
9. Berger AS, Conway M, Del Priore LV, et al. Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis. Arch Ophthalmol 1997;115:991-996.
10. Thomas MA, Dickinson JD, Melberg NS, et al. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology 1994;101:1384-1396.
11. Holekamp NM, Thomas MA, Dickinson JD, Valluri S. Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplasmosis: stability of early visual results. Ophthalmology 1997;104:22-26.
12. Melberg NS, Thomas MA, Dickinson JD, Valluri S. Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome. Ophthalmology 1996;103:1064-1067.
13. Atebara NH, Thomas MA, Holekamp NM, et al. Surgical removal of extensive peripapillary choroidal neovascularization associated with presumed ocular histoplasmosis syndrome. Ophthalmology 1998;105:1598-1605.
14. Sickenberg M, et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 2000;118:327-336.
15. Saperstein DA, Rosenfeld PJ, Bressler NM, et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. Ophthalmology 2002;109:1499-1505.
16. Miller H, Miller B. Photodynamic therapy of subretinal neovascularization in the monkey eye. Arch Ophthalmol 1993;111:855-860.
17. Fingar VH, Wieman TJ, Wiehle SA, Cerrito PB. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability and leukocyte adhesion. Cancer Res 1992;52:4914-4921.
18. Schmidt-Erfurth U, Hasan T, Schomacker K, et al. In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Lasers Surg Med 1995;17:178-188.
19. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin (one-year results of 2 randomized clinical trials - TAP report 1). Arch Ophthalmol 1999;117:1329-1345.
20. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin (two-year results of 2 randomized clinical trials - TAP report 2). Arch Ophthalmol 2001;119:198-207.
21. Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Pathologic Myopia with Verteporfin (one-year results of a randomized clinical Trial - VIP report no. 1). Ophthalmology 2001;108:841-852.